Ochsner Breast Cancer Research

Ochsner Breast Cancer Research This page provides information to patients about breast cancer and breast cancer clinical trials, breast cancer treatment options.

It also provides other available resources. Visitors will not be able to post messages without approval for administrators. Ochsner Health Center - Gretna
441 Wall Boulevard, Gretna, LA 70056
Hematology/Oncology 504-371-6550

Ochsner Health Center - Algiers
3401 Behrman Place, Algiers, LA 70114
Radiation Oncology 504-371-9323

https://www.youtube.com/watch?v=HuxA_ccCnUg
08/23/2021

https://www.youtube.com/watch?v=HuxA_ccCnUg

A National Cancer Institute cancer clinical trials educational video created for people who are considering participation in a trial. The video explains and ...

On July 26, 2021, the U.S. Food and Drug Administration (FDA) approved the immunotherapy medicine Keytruda (chemical nam...
08/20/2021

On July 26, 2021, the U.S. Food and Drug Administration (FDA) approved the immunotherapy medicine Keytruda (chemical name: pembrolizumab) plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence (the cancer coming back).
Triple-negative breast cancer is:
estrogen-receptor-negative
progesterone-receptor-negative
HER2-negative
Triple-negative breast cancers are usually more aggressive, harder to treat, and more likely to recur than cancers that are hormone-receptor-positive or HER2-positive. Triple-negative breast cancers don’t usually respond to hormonal therapy medicines or medicines that target the HER2 protein.

Keytruda is a type of immunotherapy medicine known as an immune checkpoint inhibitor. Immune checkpoint inhibitors essentially take the brakes off the immune system by blocking checkpoint inhibitor proteins on cancer cells or on the T cells that respond and attack the cancer cells.

The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence.

Address

1516 Jefferson Highway
New Orleans, LA
70121

Website

Alerts

Be the first to know and let us send you an email when Ochsner Breast Cancer Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category